LIVN News and Press, LivaNova PLC From 07/26/23

2023-07-26 06:10:09 ET LivaNova PLC press release ( NASDAQ: LIVN ): Q2 Non-GAAP EPS of $0.78 beats by $0.24 . Revenue of $293.9M (+15.6% Y/Y) beats by $28.86M . Full-Year 2023 Guidance: LivaNova now expects revenue for full-year 2023 to grow between 8% an...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights 1 Second-quarter revenue of $293.9 million increased 15.6% on a reported ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its second-quarter 2023 results on Wednesday, July 26, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2023 results prior t...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has been randomized in the RECOVER clinical study , “A P r ospective, Multi-c e nter, Randomized C ontrolled Blinded Trial Dem o ...

2023-06-12 07:48:17 ET Summary Greenlight Capital's 13F portfolio value increased by around 27% to $1.84B in Q1 2023, with the fund reporting a negative 1.3% return for the quarter. New stakes were established in Black Knight Inc., First Citizens BancShares, and New York Community...

2023-05-11 05:34:13 ET Summary LivaNova hasn't rotated periodic investment capital into incremental market valuation growth for the last 2-3 years. Capital productivity has improved the last few periods, but needs upward mobility to attract investment. Investor funds are at ri...

2023-05-07 11:48:09 ET LivaNova PLC (LIVN) Q1 2023 Earnings Conference Call May 3, 2023 08:00 ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development William Kozy - Chairman & Interim Chief Executive Officer Alex Shvartsburg - C...

2023-05-03 06:14:24 ET LivaNova PLC press release ( NASDAQ: LIVN ): Q1 Non-GAAP EPS of $0.43 beats by $0.04 . Revenue of $263.4M (+9.7% Y/Y) beats by $19.97M . LivaNova now expects revenue for full-year 2023 to grow between 4 and 6 percent on a constant-curre...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights 1 First-quarter revenue of $263.4 million increased 9.7 p...

2023-04-14 17:01:46 ET LivaNova ( NASDAQ: LIVN ) on Friday announced the resignation of its CEO and preliminary Q1 revenue that was above consensus estimates. Damien McDonald resigned as LIVN's CEO, the company said in a statement , with chair of the board William Kozy app...